Real World Evidence for US Tinnitus Patients
Treated with Lenire Now Available
The first real-world analysis of 220 American tinnitus patients treated with FDA Approved Lenire at Alaska Hearing and Tinnitus is now available. Real world results were consistent with three large-scale clinical trials for Lenire. The clinical trials used by the FDA to determine the clinical effective of Lenire.
- 91.5% of patients had clinically meaningful tinnitus reduction after 12-weeks of Lenire.
- 78% had clinically meaningful reduction in tinnitus after 6-weeks of Lenire.
- 89.2% of patients said they benefited from treatment with Lenire.
Lenire is available at San Francisco Hearing Center located in San Francisco, California. Patients who wish to be assessed for Lenire can book an appointment by calling 415-346-6886, emailing info@sfhearingcenter.com or booking an appointment online here.
In this study conducted from May 2023 – March 2024, 220 people with moderate or worse tinnitus participated in the study. Of those 159 were male and 61 were female. The average participant age was 60 and together they had a mean length of tinnitus of 8.5 years! Many of those who participated felt they benefited from Lenire and experienced a lasting and meaningful reduction in their tinnitus.
Watch Inspiring Lenire Patient Stories
Watch real world patients share their stories about getting relief from tinnitus using Lenire in their own words.
Visit Lenire’s Patient Stories page to hear how Lenire helped a pilot overcome tinnitus turbulence and stay airborne, a business leader get relief after 20-years, and many more inspiring stories.
